Genetic-based Biomarkers and Next-Generation Sequencing (NGS)

Biomarkers have several uses in pharmaceutical R & D. With the recent introduction of high performance instrumentation, protein and gene arrays and bioinformatics, clinical decisions like Drug development and choosing type of treatment can be made efficiently. However, there is a lack of valid biomarkers to increase the drug development from pre-clinical through all levels of clinical studies. Biomarker in Drug Discovery can also lead to development of Personalized Medicines.

  • NGS for the discovery of Biomarkers
  • MicroRNA sequencing for the prediction of diseases
  • SNP as Biomarkers
  • Cytogenetic & Oxidative stress Biomarkers
  • Genetic-based Biomarkers and NGS in personalized care of Cancer

Related Conference of Genetic-based Biomarkers and Next-Generation Sequencing (NGS)

July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Genetic-based Biomarkers and Next-Generation Sequencing (NGS) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in